SPRB
Price:
$0.535
Market Cap:
$22.10M
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction and clinical consequences in adult patients with classic CAH that is Phase 2b clinical trial. It is also developing tildacerfont for the treatment of pediatric classic congenital adrenal hyperplasia in children that is in Phase 2 clinical trial; and for females with polycystic ovar...[Read more]
Industry
Biotechnology
IPO Date
2020-10-09
Stock Exchange
NASDAQ
Ticker
SPRB
According to Spruce Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.51. This represents a change of -67.11% compared to the average of -1.55 of the last 4 quarters.
The mean historical PE Ratio of Spruce Biosciences, Inc. over the last ten years is -10.21. The current -0.51 PE Ratio has changed 399.72% with respect to the historical average. Over the past ten years (40 quarters), SPRB's PE Ratio was at its highest in in the June 2024 quarter at -0.60. The PE Ratio was at its lowest in in the December 2020 quarter at -15.70.
Average
-10.21
Median
-5.44
Minimum
-28.59
Maximum
-0.57
Discovering the peaks and valleys of Spruce Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 310.14%
Maximum Annual PE Ratio = -0.57
Minimum Annual Increase = -87.04%
Minimum Annual PE Ratio = -28.59
Year | PE Ratio | Change |
---|---|---|
2023 | -2.35 | 310.14% |
2022 | -0.57 | -76.48% |
2021 | -2.44 | -87.04% |
2020 | -18.83 | -34.14% |
2019 | -28.59 | 238.77% |
The current PE Ratio of Spruce Biosciences, Inc. (SPRB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.79
5-year avg
-10.56
10-year avg
-10.21
Spruce Biosciences, Inc.’s PE Ratio is greater than Inozyme Pharma, Inc. (-3.09), greater than Day One Biopharmaceuticals, Inc. (-17.12), greater than Terns Pharmaceuticals, Inc. (-5.51), greater than Eledon Pharmaceuticals, Inc. (-2.72), greater than HOOKIPA Pharma Inc. (-0.97), less than X4 Pharmaceuticals, Inc. (6.04), greater than Acumen Pharmaceuticals, Inc. (-2.73), greater than VectivBio Holding AG (-7.94),
Company | PE Ratio | Market cap |
---|---|---|
-3.09 | $277.29M | |
-17.12 | $1.49B | |
-5.51 | $599.50M | |
-2.72 | $280.20M | |
-0.97 | $45.33M | |
6.04 | $89.59M | |
-2.73 | $177.24M | |
-7.94 | $1.06B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spruce Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Spruce Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Spruce Biosciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Spruce Biosciences, Inc. (SPRB)?
What is the highest PE Ratio for Spruce Biosciences, Inc. (SPRB)?
What is the 3-year average PE Ratio for Spruce Biosciences, Inc. (SPRB)?
What is the 5-year average PE Ratio for Spruce Biosciences, Inc. (SPRB)?
How does the current PE Ratio for Spruce Biosciences, Inc. (SPRB) compare to its historical average?